期刊文献+

肾细胞癌组织中△Np63和MDM2蛋白的表达及其临床意义

EXPRESSION AND CLINICAL SIGNIFICANCE OF △Np63 AND MDM2 PROTEINS IN RENAL CELL CARCINOMA
下载PDF
导出
摘要 目的探讨△Np63和MDM2蛋白在肾细胞癌组织中的表达及其与肿瘤侵袭与转移的关系。方法应用免疫组织化学SP法,检测76例肾细胞癌和14例正常肾组织中△Np63和MDM2蛋白的表达。结果肾癌组织与正常肾组织中△Np63、MDM2蛋白的表达差异有显著性(F=28.34、22.57,q=6.471~12.529,P〈0.05);不同病理类型的肾癌组织中△Np63、MDM2蛋白的表达差异均无显著性(q=0.093~2.169,P〉0.05);不同临床分期肾癌组织中△Np63、MDM2蛋白的表达差异有显著性(F=24.59、10.82,q=4.694~11.971,P〈0.05)。△Np63和MDM2蛋白的表达存在着显著相关性(rs=0.513,P〈0.05)。结论△Np63和MDM2蛋白可以作为反映肾细胞癌侵袭和转移潜能的生物学指标。 Objective To explore the expressions of △Np63 and MDM2 proteins in renal cell carcinoma (RCC) and their relationship with the tumor invasion and metastasis. Methods Using immunohistochemical method, △Np63 and MDM2 in 76 RCC, and 14 normal renal tissues were detected. Results The expressions of △Np63 and MDM2 inRCCandin normal renaltis sue showed significantly different between them (F=28.34,22.57;q=6. 471-12. 529;P〈0.05) ; which were not related to pathological type (q=0.093--2.169,P〉0. 05), but related to clinical staging (F=24. 59,10. 82;q=4. 694--11. 971;P〈0. 05). There was significant correlation between the expressions of △Np63 and MDM2 (r,=0. 513,P〈0. 05). Conclusion The ex pressions of △Np63 and MDM2 may be used as biological parameters reflecting invasion and metastasis of this cancer.
作者 赵海军
出处 《青岛大学医学院学报》 CAS 2008年第4期314-316,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 肾肿瘤 △NP63 原癌基因蛋白质c-mdm2 免疫组织化学 Kidney neoplasms △Np63 Proto oncogene proteins c-mdm2 Immunohistochemistry
  • 相关文献

参考文献6

  • 1LEVRETO M, LAURENZI V D, COSTUNZO, et al. Structure function and regulation of p63 and p73[J]. Cell Death and Differentiation, 1999,6:1146- 1153.
  • 2PATTURAJAN M, HIBI K, TRINK B, et al. AIS is an oneogene amplified in squamous cell eareinoma [J]. Proc Natl Acad Sci USA, 2000,97(10):5462- 5467.
  • 3张鲁伟,周荣祥.膀胱移行细胞癌组织ΔNp63和MDM2蛋白表达及意义[J].青岛大学医学院学报,2007,43(5):446-448. 被引量:3
  • 4CAHILLY SNYDER L, YANG-FENG T, FRANCKE U, et al. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line[J]. Somat Cell Mol Genet, 1987,13:235-244.
  • 5HU H, XIA S H, LI A D, et al. Association of p63 with proliferative potential in normal and neoplastic human keratino cytes[J]. Invest Dermatol, 1999,113 : 1099-1105.
  • 6OLINER J D, KINZLER K W, MELTZER P S, et al. Amplification of a gene encoding a p53-assoeiated protein in human sareomas[J]. Nature,1992,358(6381) :80-83.

二级参考文献16

  • 1张玉江,王美芝,张海平,张岫美,王春波.P53蛋白、EGFR和P物质在扇贝多肽保护的中波紫外线辐射无毛小鼠皮肤中的表达[J].青岛大学医学院学报,2004,40(2):128-130. 被引量:3
  • 2罗波,张劲峰.环氧化酶-2蛋白在膀胱移行细胞癌中的表达及意义[J].青岛大学医学院学报,2005,41(3):235-236. 被引量:8
  • 3ADANYI M, CHA C, LEWIS R, et al. MDM2 gene amplification in metastatic osteosareoma[J]. Cancer Res, 1993, 53 (1):8-16.
  • 4REIS FILHO J S, SIMPSON P T, MARTINS A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray[J]. Virch Arch, 2003, 443 : 122-132.
  • 5YANG A, KAGHAD M, WANY Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities[J]. Mol Cell, 1998,2:305-316.
  • 6CELLI J, DUIJF P, HAMEL B, et al. Heterozygous germline muations in the p53 homolog p63 are the cause of EEC syndrome[J]. Cell, 1999,99:143-153.
  • 7YANG A, CKEON. p63 and p73 :p53 mimics, menaces and more[J]. Nat Rev Mol Cell Biol, 2000,1:199-207.
  • 8HU H, XIA S H, LI A D, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes[J]. Invest Dermatol, 1999,113:1099-1105.
  • 9ICHARD Z R. Prognositic impact of p63 and p53 expression in upper urinary tract transitional cell carcinaoma[J]. Urology, 2004,54 : 1079-1083.
  • 10MARSHALL J, CHARLES J. Loss of p63 expression is assoelated with tumor progression in bladder[J]. Cancer Am J Path, 2002,161:1199-1206.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部